Washington, D.C. – The American Clinical Laboratory Association (ACLA) today issued the following statement after the U.S. Food and Drug Administration (FDA) released a proposed ... Read More
Washington, D.C. – The American Clinical Laboratory Association (ACLA), along with 44 stakeholders, sent a letter to Medicare Administrative Contractors (MACS), Novitas Solutions Medical Affairs ... Read More
Washington, D.C. – The American Clinical Laboratory Association has joined with more than 30 health care provider organizations to urge House and Senate leadership to protect ... Read More
Washington, D.C. – The American Clinical Laboratory Association (ACLA) today issued the following statement as the federal government’s formal declaration of a Public Health Emergency (PHE) ... Read More
Washington, D.C. – The American Clinical Laboratory Association (ACLA) released the following statement in response to the Biden-Harris Administration designating fentanyl-xylazine as an emerging threat: “The ... Read More
Washington, D.C. – The American Clinical Laboratory Association (ACLA) has welcomed Sarah Thibault-Sennett, PhD, as Senior Director of Reimbursement Policy. “Sarah’s deep knowledge of reimbursement ... Read More
Washington D.C. – The American Clinical Laboratory Association (ACLA) released the following statement in response to a Texas court striking down an Affordable Care Act (ACA) provision ... Read More
Association Relaunches ‘Stop Lab Cuts’ Campaign Washington, D.C. – The American Clinical Laboratory Association (ACLA) today welcomed the bipartisan and bicameral introduction of the Saving ... Read More
Washington, D.C. – The American Clinical Laboratory Association (ACLA) announced the election of its Board officers for 2023-2024, confirmed by a membership vote today at the Association’s ... Read More
The 2023 Omnibus provides critical relief for labs and patients Washington, D.C. – The American Clinical Laboratory Association (ACLA) commends inclusion in the 2023 Omnibus Appropriations Bill ... Read More
